Correction to: An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer

Saved in:
Bibliographic Details
Published in:The oncologist (Dayton, Ohio) Ohio), 2023-05, Vol.28 (5), p.e313-e313
Main Authors: Mathews, Cara, Lorusso, Domenica, Coleman, Robert L, Boklage, Susan, Garside, Jamie
Format: Article
Language:English
Subjects:
Antimitotic agents
Antineoplastic agents
Cancer
Care and treatment
Comparative analysis
Diseases
Endometrial cancer
Notice
Relapse
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-7159
1549-490X
DOI:10.1093/oncolo/oyac250